Next Article in Journal
Impact of Primary Diagnosis on the Outcome of Heart Transplantation in Children
Previous Article in Journal
A Sphincter-like Function of Pulmonary Vein Ostia in Normal and Atrial Fibrillation Subjects
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Assessment of Age and Sex Difference in Cardiopulmonary Function of Children and Adolescents with Ventricular Septal Defect

1
Department of Physical Medicine and Rehabilitation, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan
2
Department of Physical Medicine and Rehabilitation, Kaohsiung Medical University Gangshan Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan
3
Department of Physical Medicine and Rehabilitation, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan
4
Department of Physical Medicine and Rehabilitation, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80756, Taiwan
5
Neurotechnology and Assistive Technology Center, Kaohsiung Medical University, Kaohsiung 80756, Taiwan
*
Author to whom correspondence should be addressed.
J. Cardiovasc. Dev. Dis. 2025, 12(6), 204; https://doi.org/10.3390/jcdd12060204
Submission received: 8 February 2025 / Revised: 29 April 2025 / Accepted: 19 May 2025 / Published: 28 May 2025

Abstract

:
In the past, an isolated ventricular septal defect (VSD) was categorized as a simple lesion with assumed negligible long-term risks when treated correctly in childhood; however, evidence has suggested that patients with isolated congenital VSDs carry a substantial burden of cardiovascular morbidity throughout life. This study aimed to investigate the cardiopulmonary function (CPF) in isolated VSD patients of a young age and the relationship of CPF with age, sex and body mass index (BMI). This retrospective cohort study was conducted at a tertiary medical center in southern Taiwan. We recruited children and adolescents (aged 5 to 18 years) with isolated VSDs who underwent the symptom-limited treadmill exercise test. Data from 289 children and adolescents (157 males, 132 females) were included in the analysis. The participants were stratified into three groups according to age. The male patients had a significantly higher oxygen uptake at the anaerobic threshold (AT VO2) and a higher peak oxygen uptake (peak VO2) (all p < 0.05). Normalized AT VO2 (mL/kg/min) and normalized peak VO2 (mL/kg/min) were significantly negatively associated with BMI. In conclusion, male patients with isolated VSDs had similar or better CPF compared with female patients. BMI had a negative association with CPF in young VSD patients.

1. Introduction

A ventricular septal defect (VSD) is the most common type of congenital heart disease (CHD). The global prevalence of VSD is 30.71 per 10,000 births, and VSD contributes 35.56% to the total burden of CHD [1]. The prevalence of VSDs in Taiwan is 29.47 per 10,000 births [2]. VSDs can occur in isolation or as an integral component of complex lesions and can be further categorized by their location and the structures along their borders [3]. A septal defect might spontaneously close or require interventional closure.
In the past, an isolated VSD was categorized as a simple lesion with assumed negligible long-term risks when treated correctly in childhood. However, the evidence suggests that patients with isolated congenital VSDs carry a substantial burden of cardiovascular morbidity throughout life, including arrhythmias, infectious endocarditis, heart failure and pulmonary arterial hypertension [4]. Patients with isolated VSDs also have a lower survival compared with that of the general population [5].
An increasing number of studies has shown that adults with isolated VSDs who have undergone surgical closure in early childhood have a reduced pulmonary function, impaired right ventricular function and a lower peak heart rate and exercise capacity [6,7,8,9]. Even patients with isolated VSDs that are considered hemodynamically insignificant have demonstrated significantly impaired minute ventilation (VE), peak oxygen uptake (peak VO2) and biventricular contractility and abnormal right ventricular function [8,10]. Patients with isolated VSDs have demonstrated a worse exercise capacity than that of their healthy peers. This difference increases with advancing age and increases mostly in patients with operated isolated VSDs [11].
Cardiopulmonary fitness (CPF) is defined as the overall capacity of the cardiovascular and respiratory systems to carry out prolonged strenuous exercise and is one of the most important components of physical fitness related to lower morbidity and mortality in healthy adults [12]. Cardiopulmonary exercise testing (CPET) is considered the gold standard for measuring CPF, providing valuable diagnostic and prognostic information and guidance for safe participation in exercise [12,13]. Several parameters have been widely used as indicators of CPF, including VO2 at the anaerobic threshold (AT) and peak VO2.
Sex differences in prognosis have been reported in adults with congenital heart disease. In a previous study, females were at higher risk of pulmonary hypertension and at lower risk of poor aortic outcomes, endocarditis and implantable cardioverter–defibrillator complications [14]. Although the mechanism of the sex difference remains uncertain, exercise capacity could be a good predictor of late complications and major adverse cardiovascular events in CHD [15,16]. No study has directly discussed the sex difference in CPF in patients with CHD; however, a trend of males having better CPF than females is noticed within the available data [15,17]. In children and adolescents with CHD, males have better CPF compared with females, and the sex difference is less than that in healthy controls [15]. Obesity also appears to be an important issue for patients with CHD, and up to 25% of children with congenital heart disease are obese or overweight [18]. Such a condition in these patients might increase their cardiovascular risk and impair their exercise capacity [19].
Although VSDs are the most common form of CHD, the existing data on the exercise performance of children with isolated VSDs remain scarce and inconsistent [20,21,22,23]. This study therefore aimed to investigate the cardiopulmonary function of isolated VSD patients of a young age and the relationship of cardiopulmonary function with age, sex and body mass index (BMI).

2. Materials and Methods

2.1. The Study Design

This retrospective cohort study was conducted at a tertiary medical center in southern Taiwan and was approved by the Institutional Review Board (No. VGHKS15-CT7-05). We recruited children and adolescents (aged 5 to 18 years) with isolated VSDs who underwent regular follow-ups at a clinic between September 2015 and August 2022. The inclusion criteria were children with isolated VSDs who had undergone the symptom-limited treadmill exercise test under the ramped Bruce protocol. The exclusion criteria were (a) incomplete CPET and (b) recent hospitalization due to heart disease or other major diseases. Thei basic demographics was recorded, including age, sex, weight, height and BMI.

2.2. The Cardiopulmonary Exercise Testing (CPET)

Informed consent was acquired prior to the tests. Before the treadmill exercise testing, each patient was familiarized with the procedures and equipment, and they underwent the exercise testing according to the ramped Bruce protocol using the MetaLyzer 3B (Cortex Biophysik GmbH Co., Leipzig, Germany) system. Throughout the test, the participant’s blood pressure, heart rate (HR), respiratory exchange ratio (RER), minute ventilation (VE), oxygen consumption (VO2) and carbon dioxide production (VCO2) were recorded and monitored. The test was terminated when the patients demonstrated unbearable symptoms. All CPET trials were performed under the supervision of an experienced physiatrist.
The main CPF indicators included VO2 at the anaerobic threshold (AT) and peak VO2. We divided AT VO2 and peak VO2 by body mass and expressed this as the normalized AT VO2 (mL/kg/min) and normalized peak VO2 (mL/kg/min) for short. The anaerobic threshold (AT) was determined using the VE/VO2 and VE/VCO2 methods [24]. Physiological criteria for the completion of a valid peak VO2 test included two of the following three criteria: (1) a peak HR within 5% of the age-predicted maximum, (2) a RER ≥ 1.0, and (3) volitional fatigue [13,25].

2.3. The Statistical Analysis

The statistical analyses were performed using SPSS Statistics version 20 (IBM Corp., Armonk, New York, NY, USA). Continuous data was expressed as means ± standard deviation, and categorical variables were presented as absolute numbers and percentages. Normality and homoscedasticity were checked prior to each analysis. The correlation between BMI and aerobic fitness (AT VO2, peak VO2 and peak PD) in all subjects was examined using a Pearson’s correlation analysis for normally distributed variables and a Spearman’s correlation analysis for non-normally distributed variables. A p-value ≤ 0.05 was considered significant.

3. Results

A total of 303 patients were recruited initially, of whom 9 (2.7%) were excluded due to incomplete data records. Five (1.5%) patients who failed to meet the criteria for maximal effort were also excluded. Finally, data from 289 children and adolescents (157 males, 132 females) were included in the analysis. The participants were stratified into three groups according to age: group 1 (aged 5–9) included 44 males and 35 females; group 2 (aged 10–13) included 44 males and 50 females; and group 3 (aged 14–18) included 69 males and 47 females. The demographic results are presented in Table 1. No differences in body weight, body height or BMI were noted between the males and females in groups 1 and 2. The boys in group 3 had significantly higher body weights, body heights and BMIs compared with these values for the girls in this group.
Table 2 presents the differences in CPF between sexes in the three age groups. Boys had significantly higher AT VO2 values and peak VO2 values than girls in the two older groups (all p < 0.05). No significant differences in AT VO2 and peak VO2 between the males and females in group 1 were found; overall, the boys had significantly higher AT VO2 and higher peak VO2 values than the girls (all p < 0.05).
The correlation between BMI and performance in the exercise test is presented in Table 3. Absolute AT VO2 (mL/min) and peak VO2 (mL/min) were positively associated with BMI. The correlation coefficient ranged from 0.164 to 0.644 for AT VO2 (mL/min) and from 0.151 to 0.664 for peak VO2 (mL/min). The normalized AT VO2 and normalized peak VO2 were significantly negatively associated with BMI. The correlation coefficient ranged from −0.580 to −0.100 for normalized AT VO2 and from −0.599 to −0.329 for normalized peak VO2, respectively.

4. Discussion

This was a retrospective study that recruited more than 250 patients with isolated VSDs aged younger than 18. The results revealed that the male patients with isolated VSDs had a similar or better CPF compared with the female patients. In addition, BMI had negative association with CPF in the children with isolated VSDs.
According to the growth charts for Taiwanese children and adolescents, the body weights and body heights of our patients were around the 50th percentile, and nearly half of our patients were within the normal BMI group [26]. In our study, significant differences in body weight, body height and BMI between males and females were noticed in the isolated VSD patients in group 3 (ages 14–18). A similar pattern was also noticed in a previous study of healthy children and adolescents [27]. In normal children within the same age range, this phenomenon could also be seen in the growth charts, in which the 50th percentile for body weight and body height for girls fell within the 25th to 50th percentile for boys aged 5 to 14 and within the 3rd to 25th percentile for boys aged 15 to 17, indicating different ranges of growth spurts between sexes [26].
In our study, peak VO2 increased with age in both sexes, but males had significantly higher AT VO2 and higher peak VO2 values than those of females in groups 2 and 3; however, no significant differences in AT VO2 and peak VO2 were found between males and females in group 1 (age 5–9). The difference in the peak VO2 between males and females also increased with age [27,28]. In healthy children and adolescents from Taiwan, males had an 8.1% to 25.2% higher normalized peak VO2 compared to that for females in one study [27]. In other studies, males had a 10.6% to 32.4% higher normalized peak VO2 compared to that in females [29,30,31]. In our study, males only had a 1.9% to 17.7% higher normalized peak VO2 compared to that in females. The differences in CPF between males and females could be partially explained by the differences in their fat-free mass and hemoglobin concentrations [28,32]; furthermore, females usually have more sedentary lifestyles and are involved in lower levels of moderate to vigorous physical activity, which could lead to a poor CPF [33]. In previous studies that have evaluated the CPF of children and adolescents with VSDs using CPET, the results have been inconsistent [15,20,21,22,23]. The normalized peak VO2 ranged from 34 to 45 mL/min/kg, which is approximately 20–25% higher compared with our data (27.98–35.48 mL/min/kg) [15,20,21,23]. This difference might be related to ethnicity or different lifestyles. In previous studies, authors have analyzed the possible determinants of physical fitness in patients with CHD, with the results showing that active motivators are viewed as an important modifiable determinant [34]. Other studies have identified low self-efficacy, covert fears, discomfort and physical fatigue as limiting factors in children with CHD [35]. A lack of education concerning proper exercise could also be an important limiting factor [36]. Due to such factors, patients may have less active lifestyles and an inferior CPF compared with the norm.
Reviewing studies about the CPF of VSD patients, most patients are recruited in adulthood for evaluation of their long-term outcomes, and little CPET data for patients with isolated VSDs aged younger than 18 exists. As far as the CPF of adults diagnosed with VSDs is concerned, most studies have revealed an inferior CPF in either field tests or laboratory tests compared with that in a normal control group [10,11]. Possible mechanisms include abnormal cardiac contractility or an abnormal ventilation response [6,7,8,9,10,23].
In our study, a negative association between BMI and CPF was noticed in this population of young isolated VSD patients. In the general population within the same age range, a negative association between BMI and CPF has also been noticed [27,37]. In the general population of Taiwan, children with a normal weight status had an 8.73% to 16.2% higher normalized peak VO2 compared to that in overweight children in one study [27]. In one systemic review article that included nine studies and 478 cases at ages between 12 and 18 years, lean adolescents had a 7.35% to 70.6% higher normalized peak VO2 compared to that in obese adolescents [38].
In addition, congenital heart disease (CHD) survivors with obesity have a higher risk of cardiac-related morbidity and mortality as compared to that in those with a normal weight status [39,40]. Due to this negative association, body weight control is also a major issue for patients with VSDs.
This study had the following limitations. Firstly, our research was conducted in a single medical center, so its results might not apply to all isolated VSD patients. Secondly, patients with severely impaired cardiac functions and patients who refused to undergo CPET were excluded. Thirdly, our research only analyzed CPET data and demographic data without consideration of cardiac imaging nor the application of a daily activity questionnaire for a more comprehensive analysis. Lastly, a national survey of the participation of the Taiwanese population of young VSD patients in physical activity is lacking, which would provide additional evidence to support our inference about the causes of the sex difference.

5. Conclusions

In conclusion, male patients with isolated VSDs had a similar or better CPF compared with female patients. BMI had a negative association with CPF in young patients with VSDs. Further investigations in the form of prospective and well-designed studies are needed to confirm the conclusions of our study.

Author Contributions

Conceptualization: C.-R.L., Y.-J.C., Y.-F.L., I.-C.H. and K.-L.L. Methodology: Y.-J.C., C.-H.C., Y.-F.L., I.-C.H. and K.-L.L. Validation: C.-R.L., Y.-J.C., C.-H.C. and K.-L.L. Formal analysis: C.-R.L., Y.-J.C. and K.-L.L. Investigation: C.-R.L., Y.-J.C., C.-H.C. and K.-L.L. Data curation: C.-R.L., Y.-J.C., C.-H.C. and K.-L.L. Writing—original draft preparation: C.-R.L. and Y.-J.C. Writing—review and editing: C.-H.C., Y.-F.L., I.-C.H. and K.-L.L. Visualization: C.-R.L., C.-H.C. and K.-L.L. Supervision: C.-H.C. and K.-L.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Kaohsiung Veteran General Hospital (protocol code: No. VGHKS15-CT7-05; date of approval: 20150612).

Informed Consent Statement

Informed consent was obtained from all of the subjects involved in this study.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author(s).

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Liu, Y.; Chen, S.; Zühlke, L.; Black, G.C.; Choy, M.-K.; Li, N.; Keavney, B.D. Global birth prevalence of congenital heart defects 1970-2017: Updated systematic review and meta-analysis of 260 studies. Int. J. Epidemiol. 2019, 48, 455–463. [Google Scholar] [CrossRef]
  2. Chen, L.J.; Chiou, J.Y.; Huang, J.Y.; Su, P.H.; Chen, J.Y. Birth defects in Taiwan: A 10-year nationwide population-based, cohort study. J. Formos. Med. Assoc. 2020, 119 Pt 3, 553–559. [Google Scholar] [CrossRef]
  3. Lopez, L.; Houyel, L.; Colan, S.D.; Anderson, R.H.; Béland, M.J.; Aiello, V.D.; Bailliard, F.; Cohen, M.S.; Jacobs, J.P.; Kurosawa, H.; et al. Classification of Ventricular Septal Defects for the Eleventh Iteration of the International Classification of Diseases-Striving for Consensus: A Report From the International Society for Nomenclature of Paediatric and Congenital Heart Disease. Ann. Thorac. Surg. 2018, 106, 1578–1589. [Google Scholar] [CrossRef]
  4. Eckerstrom, F.; Nyboe, C.; Redington, A.; Hjortdal, V.E. Lifetime Burden of Morbidity in Patients With Isolated Congenital Ven-tricular Septal Defect. J. Am. Heart Assoc. 2023, 12, e027477. [Google Scholar] [CrossRef]
  5. Eckerstrom, F.; Nyboe, C.; Maagaard, M.; Redington, A.; Hjortdal, V.E. Survival of patients with congenital ventricular septal defect. Eur. Heart J. 2023, 44, 54–61. [Google Scholar] [CrossRef]
  6. Heiberg, J.; Petersen, A.K.; Laustsen, S.; Hjortdal, V.E. Abnormal ventilatory response to exercise in young adults operated for ventricular septal defect in early childhood: A long-term follow-up. Int. J. Cardiol. 2015, 194, 2–6. [Google Scholar] [CrossRef]
  7. Rex, C.E.; Eckerström, F.; Heiberg, J.; Maagaard, M.; Rubak, S.; Redington, A.; Hjortdal, V.E. Surgical closure of a ventricular septal defect in early childhood leads to altered pul-monary function in adulthood: A long-term follow-up. Int. J. Cardiol. 2019, 274, 100–105. [Google Scholar] [CrossRef]
  8. Maagaard, M.; Eckerstrom, F.; Redington, A.; Hjortdal, V. Comparison of Outcomes in Adults With Ventricular Septal Defect Closed Earlier in Life Versus Those in Whom the Defect Was Never Closed. Am. J. Cardiol. 2020, 133, 139–147. [Google Scholar] [CrossRef]
  9. Jablonsky, G.; Hilton, J.D.; Liu, P.P.; Morch, J.E.; Druck, M.N.; Bar-Shlomo, B.-Z.; McLaughlin, P.R.; Winter, K.M. Rest and exercise ventricular function in adults with congenital ventricular septal de-fects. Am. J. Cardiol. 1983, 51, 293–298. [Google Scholar] [CrossRef]
  10. Eckerström, F.; Rex, C.E.; Maagaard, M.; Heiberg, J.; Rubak, S.; Redington, A.; Hjortdal, V.E. Cardiopulmonary dysfunction in adults with a small, unrepaired ventricular septal defect: A long-term follow-up. Int. J. Cardiol. 2020, 306, 168–174. [Google Scholar] [CrossRef]
  11. Maagaard, M.; Eckerstrom, F.; Boutrup, N.; Hjortdal, V.E. Functional Capacity Past Age 40 in Patients With Congenital Ventricu-lar Septal Defects. J. Am. Heart Assoc. 2020, 9, e015956. [Google Scholar] [CrossRef] [PubMed]
  12. Takken, T.; Bongers, B.C.; van Brussel, M.; Haapala, E.A.; Hulzebos, E.H.J. Cardiopulmonary Exercise Testing in Pediatrics. Ann. Am. Thorac. Soc. 2017, 14 (Suppl. 1), S123–S128. [Google Scholar] [CrossRef]
  13. Rottermann, K.; Weigelt, A.; Stabler, T.; Ehrlich, B.; Dittrich, S.; Schoffl, I. New kids on the CPET: Age-appropriate outdoor cardio-pulmonary exercise testing in preschoolers. Eur. J. Appl. Physiol. 2022, 122, 791–800. [Google Scholar] [CrossRef]
  14. Verheugt, C.L.; Uiterwaal, C.S.; van der Velde, E.T.; Meijboom, F.J.; Pieper, P.G.; Vliegen, H.W.; van Dijk, A.P.; Bouma, B.J.; Grobbee, D.E.; Mulder, B.J. Gender and outcome in adult congenital heart disease. Circulation 2008, 118, 26–32. [Google Scholar] [CrossRef]
  15. van Genuchten, W.J.; Helbing, W.A.; Harkel, A.D.J.T.; Fejzic, Z.; Kuipers, I.M.; Slieker, M.G.; van der Ven, J.P.G.; Boersma, E.; Takken, T.; Bartelds, B. Exercise capacity in a cohort of children with congenital heart dis-ease. Eur. J. Pediatr. 2023, 182, 295–306. [Google Scholar] [CrossRef]
  16. Das, B.B.; Godoy, A.; Kadish, T.; Niu, J. Maximal versus sub-maximal effort during cardiopulmonary exercise testing in adults with congenital heart disease: Outcome analysis of short-term cardiac-related events. Cardiol. Young 2021, 31, 91–96. [Google Scholar] [CrossRef]
  17. Eshuis, G.; Hock, J.; du Sarvaas, G.M.; van Duinen, H.; Neidenbach, R.; Heuvel, F.v.D.; Hillege, H.; Berger, R.M.; Hager, A. Exercise capacity in patients with repaired Tetralogy of Fallot aged 6 to 63 years. Heart 2022, 108, 186–193. [Google Scholar] [CrossRef]
  18. Shustak, R.J.; McGuire, S.B.; October, T.W.; Phoon, C.K.; Chun, A.J. Prevalence of obesity among patients with congenital and ac-quired heart disease. Pediatr. Cardiol. 2012, 33, 8–14. [Google Scholar] [CrossRef]
  19. Tamayo, C.; Manlhiot, C.; Patterson, K.; Lalani, S.; McCrindle, B.W. Longitudinal evaluation of the prevalence of over-weight/obesity in children with congenital heart disease. Can. J. Cardiol. 2015, 31, 117–123. [Google Scholar] [CrossRef]
  20. Binkhorst, M.; van de Belt, T.; de Hoog, M.; van Dijk, A.; Schokking, M.; Hopman, M. Exercise capacity and participation of chil-dren with a ventricular septal defect. Am. J. Cardiol. 2008, 102, 1079–1084. [Google Scholar] [CrossRef]
  21. Perrault, H.; Drblik, S.P.; Montigny, M.; Davignon, A.; Lamarre, A.; Chartrand, C.; Stanley, P. Comparison of cardiovascular adjustments to exercise in adolescents 8 to 15 years of age after correction of tetralogy of fallot, ventricular septal defect or atrial septal defect. Am. J. Cardiol. 1989, 64, 213–217. [Google Scholar] [CrossRef]
  22. Qu, J.; Shi, H.; Chen, X.; Li, K.; Liang, H.; Cui, Y. Evaluation of Physical Fitness in Children With Congenital Heart Diseases Versus Healthy Population. Semin. Thorac. Cardiovasc. Surg. 2020, 32, 906–915. [Google Scholar] [CrossRef] [PubMed]
  23. Nederend, I.; de Geus, E.J.C.; Blom, N.A.; Ten Harkel, A.D.J. Long-term follow-up after ventricular septal defect repair in children: Cardiac autonomic control, cardiac function and exercise capacity. Eur. J. Cardiothorac. Surg. 2018, 53, 1082–1088. [Google Scholar] [CrossRef] [PubMed]
  24. Washington, R.L. Cardiorespiratory testing: Anaerobic threshold/respiratory threshold. Pediatr. Cardiol. 1999, 20, 12–15, discussion 16. [Google Scholar] [CrossRef]
  25. Yu, C.C.W.; McManus, A.M.; Au, C.T.; So, H.K.; Chan, A.; Sung, R.Y.T.; Li, A.M. Appropriate scaling approach for evaluating peak VO2 development in Southern Chinese 8 to 16 years old. PLoS ONE 2019, 14, e0213674. [Google Scholar] [CrossRef]
  26. Chen, W.; Chang, M.H. New growth charts for Taiwanese children and adolescents based on World Health Organization standards and health-related physical fitness. Pediatr. Neonatol. 2010, 51, 69–79. [Google Scholar] [CrossRef]
  27. Tuan, S.H.; Chen, G.-B.; Chen, C.-H.; Chen, Y.-J.; Liou, I.-H.; Su, Y.-T.; Lin, K.-L. Comparison of Peak Oxygen Consumption During Exercise Testing Between Sexes Among Children and Adolescents in Taiwan. Front. Pediatr. 2021, 9, 657551. [Google Scholar] [CrossRef]
  28. Armstrong, N.; Welsman, J.R. Assessment and interpretation of aerobic fitness in children and adolescents. Exerc. Sport Sci. Rev. 1994, 22, 435–476. [Google Scholar] [CrossRef]
  29. Lai, N.; Fiutem, J.J.; Pfaff, N.; Salvadego, D.; Strainic, J. Relating cardiorespiratory responses to work rate during incremental ramp exercise on treadmill in children and adolescents: Sex and age differences. Eur. J. Appl. Physiol. 2021, 121, 2731–2741. [Google Scholar] [CrossRef]
  30. van der Steeg, G.E.; Takken, T. Reference values for maximum oxygen uptake relative to body mass in Dutch/Flemish subjects aged 6-65 years: The LowLands Fitness Registry. Eur. J. Appl. Physiol. 2021, 121, 1189–1196. [Google Scholar] [CrossRef]
  31. Amedro, P.; Gavotto, A.; Guillaumont, S.; Bertet, H.; Vincenti, M.; De La Villeon, G.; Bredy, C.; Acar, P.; Ovaert, C.; Picot, M.-C.; et al. Cardiopulmonary fitness in children with congenital heart diseases versus healthy children. Heart 2018, 104, 1026–1036. [Google Scholar] [CrossRef] [PubMed]
  32. Sharma, V.K.; Subramanian, S.K.; Arunachalam, V. Evaluation of body composition and its association with cardio respiratory fitness in south Indian adolescents. Indian. J. Physiol. Pharmacol. 2013, 57, 399–405. [Google Scholar] [PubMed]
  33. Van Hecke, L.; Loyen, A.; Verloigne, M.; van der Ploeg, H.P.; Lakerveld, J.; Brug, J.; De Bourdeaudhuij, I.; Ekelund, U.; Donnelly, A.; Hendriksen, I.; et al. Variation in population levels of physical activity in European children and ado-lescents according to cross-European studies: A systematic literature review within DEDIPAC. Int. J. Behav. Nutr. Phys. Act. 2016, 13, 70. [Google Scholar] [CrossRef] [PubMed]
  34. Zaqout, M.; Vandekerckhove, K.; De Wolf, D.; Panzer, J.; Bové, T.; François, K.; De Henauw, S.; Michels, N. Determinants of Physical Fitness in Children with Repaired Congenital Heart Disease. Pediatr. Cardiol. 2021, 42, 857–865. [Google Scholar] [CrossRef]
  35. Moola, F.; Faulkner, G.E.; Kirsh, J.A.; Kilburn, J. Physical activity and sport participation in youth with congenital heart disease: Perceptions of children and parents. Adapt. Phys. Act. Q. 2008, 25, 49–70. [Google Scholar] [CrossRef]
  36. Caterini, J.E.; Campisi, E.S.; Cifra, B. Physical Activity Promotion in Pediatric Congenital Heart Disease: Are We Running Late? Can. J. Cardiol. 2020, 36, 1406–1416. [Google Scholar] [CrossRef]
  37. Diez-Fernandez, A.; Sanchez-Lopez, M.; Mora-Rodriguez, R.; Notario-Pacheco, B.; Torrijos-Nino, C.; Martinez-Vizcaino, V. Obesity as a mediator of the influence of cardiorespiratory fitness on cardiometabolic risk: A mediation analysis. Diabetes Care 2014, 37, 855–862. [Google Scholar] [CrossRef]
  38. Hansen, D.; Marinus, N.; Remans, M.; Courtois, I.; Cools, F.; Calsius, J.; Massa, G.; Takken, T. Exercise tolerance in obese vs. lean adolescents: A systematic review and me-ta-analysis. Obes. Rev. 2014, 15, 894–904. [Google Scholar] [CrossRef]
  39. Jackson, J.L.; Fox, K.R.; Cotto, J.; Harrison, T.M.; Tran, A.H.; Keim, S.A. Obesity across the lifespan in congenital heart disease survi-vors: Prevalence and correlates. Heart Lung 2020, 49, 788–794. [Google Scholar] [CrossRef]
  40. Martinez, S.C.; Byku, M.; Novak, E.L.; Cedars, A.M.; Eghtesady, P.; Ludbrook, P.A.; Billadello, J.J. Increased Body Mass Index Is Associated with Congestive Heart Failure and Mortali-ty in Adult Fontan Patients. Congenit. Heart Dis. 2016, 11, 71–79. [Google Scholar] [CrossRef]
Table 1. Comparison of body composition between two sexes in relation to age group.
Table 1. Comparison of body composition between two sexes in relation to age group.
Age GroupAge 5–9Age 10–13Age 14–18All Age
SexBoys (n = 44)Girls (n = 35)p-valueBoys (n = 44)Girls (n = 50)p-valueBoys (n = 69)Girls (n = 47)p-valueBoys (n = 157)Girls (n = 132)p-value
Height126.16 ± 9.42128.10 ± 8.790.350148.72 ± 12.09146.32 ± 13.440.672168.19 ± 8.97157.05 ± 5.88<0.001150.95 ± 20.1145.31 ± 15.120.007
Weight28.85 ± 9.7229.64 ± 7.750.69543.31 ± 12.4041.55 ± 10.170.94565.02 ± 17.4651.37 ± 8.20<0.00148.8 ± 20.941.88 ± 12.260.001
BMI17.71 ± 3.5217.88 ± 3.390.83319.21 ± 4.1719.66 ± 4.200.28922.91 ± 5.6020.61 ± 3.040.00520.42 ± 5.219.52 ± 3.740.092
BMI, body mass index; p-values: comparisons between boys and girls.
Table 2. Comparison of cardiopulmonary fitness during exercise testing between two sexes in relation to age group.
Table 2. Comparison of cardiopulmonary fitness during exercise testing between two sexes in relation to age group.
Age Group ATVO2ATVO2PEAKVO2PEAKVO2Peak RER
(mL/kg/min) (mL/min)(mL/kg/min)(mL/min)(N/A)
Ages 5–9 Boys (n = 44)25.42 ± 5.37722.99 ± 262.2335.48 ± 6.431007.08 ± 354.641.14 ± 0.09
Girls (n = 35)25.38 ± 4.56736.31 ± 170.2735.17 ± 3.871029.05 ± 228.951.16 ± 0.08
p-value0.9700.7960.7940.7520.343
Ages 10–13 Boys (n = 44)23.71 ± 3.871001.16 ± 224.5235.13 ± 5.911477.80 ± 316.981.15 ± 0.08
Girls (n = 50)21.74 ± 4.41894.86 ± 246.7830.28 ± 5.461243.56 ± 318.251.16 ± 0.10
p-value0.0240.032<0.0010.0010.569
Ages 14–18Boys (n = 69)22.05 ± 4.801402.38 ± 367.4632.93 ± 8.002086.66 ± 549.931.18 ± 0.08
Girls (n = 47)20.01 ± 4.581024.22 ± 267.9227.98 ± 6.241423.17 ± 328.841.22 ± 0.12
p-value0.024<0.0010.001<0.0010.063
Age 5–18Boys (n = 157)23.46 ± 4.911099.54 ± 418.3234.26 ± 7.101613.47 ± 634.141.16 ± 0.09
Girls (n = 132)22.09 ± 4.95898.88 ± 261.1830.76 ± 6.071250.63 ± 336.571.18 ± 0.10
p-value0.019<0.001<0.001<0.0010.071
Age Group Rest SBPRest DBPRest HRPeak HRPeak SBPPeak DBP
(mmHg)(mmHg)(beat/min)(beat/min)(mmHg)(mmHg)
Ages 5–9 Boys (n = 44)101.61 ± 11.1761.41 ± 7.9288.73 ± 16.20175.09 ± 15.27146.0 ± 24.181.2 ± 17.3
Girls (n = 35)99.89 ± 12.7460.69 ± 9.0289.77 ± 14.51179.09 ± 8.50155.6 ± 35.480.4 ± 19.5
p-value0.5230.7060.7670.1450.1750.850
Ages 10–13 Boys (n = 44)114.09 ± 14.7367.30 ± 7.8087.11 ± 14.86176.09 ± 9.27159.9 ± 24.183.8 ± 21.3
Girls (n = 50)107.96 ± 13.6863.84 ± 8.1786.86 ± 11.70175.90 ± 14.65156.0 ± 29.885.7 ± 20.2
p-value0.0390.0390.9270.9410.4870.655
Ages 14–18Boys (n = 69)122.97 ± 17.1571.29 ± 10.8083.68 ± 13.02177.70 ± 14.88179.5 ± 27.691.5 ± 21.5
Girls (n = 47)116.04 ± 18.5469.81 ± 9.2582.94 ± 10.34172.28 ± 15.40163.7 ± 30.390.2 ± 21.7
p-value0.0410.4440.7430.0600.0050.751
Ages 5–18Boys (n = 157)114.50 ± 17.3567.40 ± 10.0986.06 ± 14.56176.52 ± 13.62164.7 ± 29.286.5 ± 20.8
Girls (n = 132)108.70 ± 16.5265.13 ± 9.4886.23 ± 12.28175.45 ± 13.77158.6 ± 31.585.9 ± 20.8
p-value0.040.0510.9120.5120.900.804
AT VO2, oxygen consumption at anaerobic threshold; N/A, non-applicable; peak VO2, peak oxygen consumption during exercise testing; RER, respiratory exchange ratio. p-values: comparisons between boys and girls. SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate.
Table 3. Correlation between body mass index and performance in the exercise test of children and adolescents.
Table 3. Correlation between body mass index and performance in the exercise test of children and adolescents.
Age GroupATVO2ATVO2PEAKVO2PEAKVO2
(mL/kg/min)(mL/min)(mL/kg/min)(mL/min)
Age 5–9 Boys (n = 44)BMI−0.306 *0.664 **−0.386 **0.664 **
Girls (n = 35)BMI−0.527 **0.452 **−0.557 **0.636 **
Total (n = 79)BMI−0.392 **0.584 **−0.430 **0.644 **
Age 10–13 Boys (n = 44)BMI−0.580 **0.539 **−0.599 **0.536 **
Girls (n = 50)BMI−0.297 *0.164−0.347 *0.151
Total (n = 94)BMI−0.420 **0.309 **−0.452 **0.290 **
Age 14–18Boys (n = 69)BMI−0.459 **0.473 **−0.506 **0.382 **
Girls (n = 47)BMI−0.1000.412 **−0.329 *0.215
Total (n = 116)BMI−0.288 **0.502 **−0.351 **0.415 **
Age 5–18Total (n = 289)BMI−0.425 **0.568 **−0.447 **0.532 **
* p-value < 0.05, ** p-value < 0.01. AT VO2, oxygen consumption at anaerobic threshold; BMI, body mass index; peak VO2, peak oxygen consumption during exercise testing. Data are presented as Pearson’s coefficient factors (p-values).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lin, C.-R.; Liu, Y.-F.; Huang, I.-C.; Chen, Y.-J.; Chen, C.-H.; Lin, K.-L. Assessment of Age and Sex Difference in Cardiopulmonary Function of Children and Adolescents with Ventricular Septal Defect. J. Cardiovasc. Dev. Dis. 2025, 12, 204. https://doi.org/10.3390/jcdd12060204

AMA Style

Lin C-R, Liu Y-F, Huang I-C, Chen Y-J, Chen C-H, Lin K-L. Assessment of Age and Sex Difference in Cardiopulmonary Function of Children and Adolescents with Ventricular Septal Defect. Journal of Cardiovascular Development and Disease. 2025; 12(6):204. https://doi.org/10.3390/jcdd12060204

Chicago/Turabian Style

Lin, Chao-Ruei, Ya-Fen Liu, I-Ching Huang, Yi-Jen Chen, Chia-Hsin Chen, and Ko-Long Lin. 2025. "Assessment of Age and Sex Difference in Cardiopulmonary Function of Children and Adolescents with Ventricular Septal Defect" Journal of Cardiovascular Development and Disease 12, no. 6: 204. https://doi.org/10.3390/jcdd12060204

APA Style

Lin, C.-R., Liu, Y.-F., Huang, I.-C., Chen, Y.-J., Chen, C.-H., & Lin, K.-L. (2025). Assessment of Age and Sex Difference in Cardiopulmonary Function of Children and Adolescents with Ventricular Septal Defect. Journal of Cardiovascular Development and Disease, 12(6), 204. https://doi.org/10.3390/jcdd12060204

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop